See and Treat with the SRT-100 Vision for Skin Cancer Treatment
Superficial Radio Therapy is the premier choice for physicians and patients when it comes to skin cancer treatment options. With the SRT-100 Vision for Skin Cancer Treatment, physicians and patients alike, are privileged to witness the results through high-frequency ultrasound imaging. Key Features Laser Positioning System The SRT-100 Vision provides a laser positioning system for […]
Sensus Healthcare to Host First Quarter 2018 Financial Results and Business Update Conference Call on May 3, 2018
BOCA RATON, Fla., April 26, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces that management will hold a conference call on Thursday, May 3, 2018 at 4:30 p.m. Eastern time to discuss the financial results […]
Sensus Healthcare Expands International Business to Meet Rising Patient Demand for Non-Invasive Skin Cancer and Keloid Treatments
EVP Rick Golin Assumes New Role Bringing Superficial Radio Therapy to International Distributors in Asia, the Americas, Europe and the Middle East BOCA RATON, Fla., April 19, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced […]
Sensus at the 2018 Texas Dermatological Society Users Meeting
Join Sensus Healthcare at the 2018 Texas Dermatological Society Users Meeting in Austin, TX April 27-28, 2018. For tickets and more information click here.
Sensus Healthcare at ASLMS 2018
Join Sensus Healthcare at the 2018 ASLMS conference in Dallas, TX April 11-15, 2018. Come and meet the new Sensus Laser Systems. Click here to register today!
Educating Your Patients on Keloid Removal Success Rates
A keloid is a cutaneous mass that characteristically develops following a dermal injury. The keloid has beset dermatologists and cosmetic surgeons for decades, in view of both its pathological evolution and therapeutic challenges. Classically described as an overgrowth of tissue that extends beyond the borders of the original wound, keloids differ from that of hypertrophic […]
